Skip to Main Content

Author Details

Elizabeth Bancroft
The Institute of Cancer Research
2003
80
29
PMIDPaper TitleJournal TitlePublished Year
36493335CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer.J Clin Oncol2023
37025481Serum testosterone and prostate cancer in men with germline <i>BRCA1/2</i> pathogenic variants.BJUI Compass2023
34214236The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.BJU Int2022
35379327Improving hand hygiene practices in two regional hospitals in Kenya using a continuous quality improvement (CQI) approach.Antimicrob Resist Infect Control2022
35436967How can we recruit more men of African or African-Caribbean ancestry into our research? Co-creating a video to raise awareness of prostate cancer risk and the PROFILE study.Res Involv Engagem2022
36502401Infection Prevention and Control Initiatives to Prevent Healthcare-Associated Transmission of SARS-CoV-2, East Africa.Emerg Infect Dis2022
34923574Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups.Br J Cancer2022
33230029Task Shifting for Initiation and Monitoring of Antiretroviral Therapy for HIV-Infected Adults in Uganda: The SHARE Trial.J Acquir Immune Defic Syndr2021
33827543Standardizing clinical culture specimen collection in Ethiopia: a training-of-trainers.BMC Med Educ2021
34790437Updates in Prostate Cancer Research and Screening in Men at Genetically Higher Risk.Curr Genet Med Rep2021
34678156A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study.Lancet Oncol2021
31495749Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study.Eur Urol2020
32017261The New Genomics Era: Integration of genomics into mainstream oncology and implications for psycho-oncological care.Psychooncology2020
32532514Prostate Cancer Risk by BRCA2 Genomic Regions.Eur Urol2020
30527799Homeobox B13 G84E Mutation and Prostate Cancer Risk.Eur Urol2019
29802810Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations.BJU Int2019
31537406Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.Eur Urol2019
29301143Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.Br J Cancer2018
29662167Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet2018
29509747Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.Br J Cancer2018
29329280Status of HIV Epidemic Control Among Adolescent Girls and Young Women Aged 15-24 Years - Seven African Countries, 2015-2017.MMWR Morb Mortal Wkly Rep2018
28812325Ambiguity in a masculine world: Being a BRCA1/2 mutation carrier and a man with prostate cancer.Psychooncology2017
28220749Epidemiology of Invasive Haemophilus influenzae Disease, Europe, 2007-2014.Emerg Infect Dis2017
28091804Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls.Fam Cancer2017
27367496Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.JAMA Oncol2016
27151655The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.Oncologist2016
25454609Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer.Eur Urol2015
26146975Infection Prevention and Control in the Podiatric Medical Setting. Challenges to Providing Consistently Safe Care.J Am Podiatr Med Assoc2015
26196293Health Care-Associated Infection Outbreak Investigations in Outpatient Settings, Los Angeles County, California, USA, 2000-2012.Emerg Infect Dis2015
25872100The psychological impact of undergoing genetic-risk profiling in men with a family history of prostate cancer.Psychooncology2015
25944041Corrigendum to "Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study" [Eur Urol 2014;66:489-99].Eur Urol2015
25756382Infection Prevention and Control in the Podiatric Medical Setting: Challenges to Providing Consistently Safe Care.J Am Podiatr Med Assoc2015
25746941The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers.Urol Oncol2015
24389956Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers.Fam Cancer2014
26779560Diffusion-weighted MRI for detecting prostate tumour in men at increased genetic risk.Eur J Radiol Open2014
24980079"It's all very well reading the letters in the genome, but it's a long way to being able to write": Men's interpretations of undergoing genetic profiling to determine future risk of prostate cancer.Fam Cancer2014
24507465Influenza season 2013/14 has started in Europe with influenza A(H1)pdm09 virus being the most prevalent subtype.Euro Surveill2014
24656197Should we use oral polio vaccine in Europe? - Authors' reply.Lancet2014
24338352Viruses associated with acute respiratory infections and influenza-like illness among outpatients from the Influenza Incidence Surveillance Project, 2010-2011.J Infect Dis2014
24296704The genetic epidemiology of prostate cancer and its clinical implications.Nat Rev Urol2014
24377489Use of electronic death certificates for influenza death surveillance.Emerg Infect Dis2014
24489760Telomere length shows no association with BRCA1 and BRCA2 mutation status.PLoS One2014
24484606Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.Eur Urol2014
23293217Reproductive decision-making in young female carriers of a BRCA mutation.Hum Reprod2013
24295187How advances in genomics are changing patient care.Nurs Clin North Am2013
23910647Hospitalizations due to hepatitis C in Los Angeles County, 2007-2009: case characteristics and factors associated with mortality.J Viral Hepat2013
24018936Outbreak of Escherichia coli infections associated with a contaminated transesophageal echocardiography probe.Infect Control Hosp Epidemiol2013
23792811Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men.Sci Rep2013
21835502Outbreak of acute hepatitis B virus infections associated with podiatric care at a psychiatric long-term care facility.Am J Infect Control2012
22682955Beyond prostate-specific antigen - future biomarkers for the early detection and management of prostate cancer.Clin Oncol (R Coll Radiol)2012
  • 1 - 50 of 80

Recommended Authors

Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 2011
Number of shared co-authors 0
School of Cancer and Pharmaceutical Sciences, King's College London
Career Start Year 2007
Number of shared co-authors 7
Vanderbilt University School of Nursing
Career Start Year 2007
Number of shared co-authors 0
National Institutes of Health
Career Start Year 2004
Number of shared co-authors 2
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 2001
Number of shared co-authors 19
Institute for Public Health Genetics, University of Washington
Career Start Year 2000
Number of shared co-authors 2
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 1
Institute for Human Genetics, University of California san francisco
Career Start Year 1998
Number of shared co-authors 6
Stanford University
Career Start Year 1997
Number of shared co-authors 0
Department of Medicine and Moores Cancer Center, University of California San Diego.
Career Start Year 1994
Number of shared co-authors 3
Center for Health Research, Kaiser Permanente Northwest Research Center
Career Start Year 1994
Number of shared co-authors 0
Center for Health Research, Kaiser Permanente Northwest
Career Start Year 1993
Number of shared co-authors 2
Dartmouth Geisel School of Medicine
Career Start Year 1993
Number of shared co-authors 0
College of Medicine, The Ohio State University
Career Start Year 1992
Number of shared co-authors 10
College of Nursing, University of South Florida
Career Start Year 1991
Number of shared co-authors 23
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 5
University of North Carolina
Career Start Year 1989
Number of shared co-authors 1
Penn State College of Medicine, The Pennsylvania State University
Career Start Year 1988
Number of shared co-authors 1
Vanderbilt Genetics Institute, Vanderbilt University Medical Center
Career Start Year 1986
Number of shared co-authors 2
University of Washington Medical Center
Career Start Year 1985
Number of shared co-authors 1
Kaiser Permanente Northern California, University of California san francisco
Career Start Year 1985
Number of shared co-authors 13
Rollins School of Public Health, Emory University
Career Start Year 1985
Number of shared co-authors 2
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 6
National Cancer Institute, 9609 Medical Center Dr
Career Start Year 1981
Number of shared co-authors 22
National Institutes of Health
Career Start Year 1981
Number of shared co-authors 1
Centers for Disease Control and Prevention Atlanta GA USA.
Career Start Year 1981
Number of shared co-authors 4
Mayo Clinic
Career Start Year 1979
Number of shared co-authors 26
National Cancer Institute
Career Start Year 1977
Number of shared co-authors 5
The Heart Institute, Cincinnati Children's Hospital Medical Center
Career Start Year 1975
Number of shared co-authors 2
University of California San Francisco
Career Start Year 1968
Number of shared co-authors 4

Collaborators

The Institute of Cancer Research
Co-authored papers 51
The Institute of Cancer Research
Co-authored papers 27
University of Cambridge
Co-authored papers 14
Guy's and St Thomas' NHS Foundation Trust
Co-authored papers 12
Oncogenetics Team The Institute of Cancer Research London UK.
Co-authored papers 10
The Institute of Cancer Research
Co-authored papers 10
The Institute of Cancer Research
Co-authored papers 9
Co-authored papers 8
Pomeranian Medical University
Co-authored papers 8
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Co-authored papers 7
Co-authored papers 7
Oncogenetics Team The Institute of Cancer Research London UK.
Co-authored papers 7
University of Oxford
Co-authored papers 7
Co-authored papers 6
Karolinska Institute
Co-authored papers 6
Leiden University Medical Center
Co-authored papers 6
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 6
King Edward Memorial Hospital
Co-authored papers 5
Familial Cancer Centre Peter MacCallum Cancer Centre Parkville Victoria 0 Australia.
Co-authored papers 5
Familial Cancer Clinic, Hospital Sant Pau
Co-authored papers 4
Norwich Medical School, University of East Anglia
Co-authored papers 4
Royal Marsden NHS Foundation Trust
Co-authored papers 4
Segal Cancer Centre, Jewish General Hospital
Co-authored papers 4
CancerLinQ LLC, American Society of Clinical Oncology
Co-authored papers 3
University Hospital Southampton NHS Foundation Trust
Co-authored papers 3
Peter MacCallum Cancer Centre, University of Melbourne
Co-authored papers 3
University of Oxford, John Radcliffe Hospital
Co-authored papers 3
Belfast City Hospital
Co-authored papers 2
Imperial College London
Co-authored papers 2
University College London
Co-authored papers 2